Elsevier Business Intelligence (EBI) to Host Investment-in-Innovation (IN3) Medical Device 360 Dublin, April 16-18, 2013

Elsevier Business Intelligence (EBI) to Host Investment-in-Innovation (IN3) 
Medical Device 360 Dublin, April 16-18, 2013 
DUBLIN, IRELAND -- (Marketwire) -- 02/04/13 --  Elsevier Business
Intelligence, publisher of "The Gray Sheet" and the medtech
industry's leading provider of strategic partnership and investment
conferences, will host the 'Investment-in-Innovation (IN3) Medical
Device 360 Dublin' partnering and investment conference on April
16-18, 2013, at the The Shelbourne Dublin. This special event, which
will bring together a diverse group of medtech's key thought leaders
from among corporate business development execs, venture capital and
angel investors, start-up entrepreneurs and industry pioneers, will
feature a panel discussion: 
"Strategics on Deal Priorities: Driving Growth through Different
Structures." Virtually all medtech exits take place by M&A. What are
the strategics looking for when acquiring? In this interactive
session, large device company executives will share their insights
about what they like to see from smaller venture-backed companies and
how they are driving growth through M&A. Discussion points will
include: 


 
--  What is the current appetite for deals? Compared to previous years?
--  Thin pickings or window of opportunities? How suitable is the startup
    community in creating the environment to do more deals?
--  Building the infrastructure to do more deals
--  Focusing on revenue generating companies
--  Tuck-in acquisitions vs. white space deals: where to focus
--  Growth through non-traditional markets: which areas can supplement
    growth?

  
Confirmed speakers at IN3 Dublin are: David Cassak (moderator), Vice
President, Content, Elsevier Business Intelligence; Steve Levin
(moderator), Editor-in-Chief, Elsevier Business Intelligence; Chad
Cornell, Vice President, Corporate Development, Medtronic; Townsend
Goddard, Director, Business Development & Strategic Planning, Stryker
Corporation; Dennis Crowley, VP, Corporate Development & Licensing,
Covidien; Edward Andrle, VP, Business Development, Sorin Group; Zeev
Zehavi, Vice President, Venture Investments, Johnson and Johnson
Development Corporation, and Amir Blumenfeld, Head of Discovery for
Edwards Lifesciences. 
Investors confirmed to attend to date include senior-level dealmakers
from Abingworth, Delta Partners, Earlybird Venture Capital, Fountain
Healthcare Partners, Gilde, Imperial Innovations, NBGI Ventures,
Omnes Capital, Peppermint Venture Partners, Seroba Kernel, Sofinnova,
and Wellington Partners. Corporate investors confirmed to attend to
date include Bard, Covidien, Edwards Lifesciences, Johnson & Johnson,
Sorin, and Stryker.  
In addition to all of the customary conference benefits, presenting
company CEOs will have the opportunity to be interviewed on camera,
at no charge, for a 3-minute exclusive video in which they may
discuss their company and technology. These interviews will be
featured post-conference at www.in3tv.com, to which a link will be
provided to participating companies for their unrestricted use;
availability of these video interviews will be broadly promulgated
within the medtech industry. All one-on-one interviews with
presenting-company CEOs will take place at, and during the IN3 Dublin
conference and be organized by medtech PR/IR expert Ronald Trahan,
President of Ronald Trahan Associates, Inc. Videotaping will take
place on a scheduled basis only, on one day only of the event:
Wednesday, April 17, from 13:00-17:30 local time. To schedule the
free on-camera interviews contact rctrahan@ronaldtrahan.com, or call
+1-508-359-4005, x108. 
IN3 Medical Device 360 Dublin will be held at The Shelbourne Dublin.
Event co-sponsors include Ronald Trahan Associates Inc., Aptiv
Solutions, Enterprise Ireland, Eugene F. Collins, KPMG, Seroba
Kernel, and Marketwire. Visit www.in3dublin.com for full conference
and registration details.  
This two-day special event will benefit a wide variety of
participants in the medical device sector: start-ups seeking
investment or strategic partnerships, investment firms, VCs, mid-size
and large medical device manufacturers, and service providers.
Emerging medtech companies that would like to apply to present in
Dublin should contact Kayleen Kell at 949-797-7142, or email
k.kell@elsevier.com 
About Elsevier Business Intelligence
 Elsevier Business Intelligence
(EBI), an Elsevier company built on the heritage of F-D-C Reports,
Windhover Information and Medtech Insight, is a global information
supplier providing business intelligence on regulatory, business and
reimbursement issues that are vital to the healthcare industry.
Through a range of products including publications, conferences,
databases and reports, EBI places biopharma and medical device
professionals, and those who focus on these industries, at the
forefront of knowledge, by providing the perfect combination of news
and information together with penetrating insight and analysis. EBI
(www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.;
Norwalk, Conn.; Rockville, Md.; and Irvine, Calif. 
Contact: 
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108